AMGN Jun 2023 345.000 call

OPR - OPR Prezzo differito. Valuta in USD.
4,2500
0,0000 (0,00%)
Al 10:39AM EDT. Mercato aperto.
Il grafico dei titoli non è supportato dal tuo browser attuale
Chiusura precedente4,2500
Aperto4,2500
Denaro1,7200
Lettera3,2000
Prezzo d'esercizio345,00
Scadenza2023-06-16
Min-Max giorno4,2500 - 4,2500
Contratto - Min-MaxN/D
Volume100
Open Interest100
  • GlobeNewswire

    Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

    Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and Amgen’s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan’s proprietary target discovery